These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20804896)

  • 21. [Cutaneous lymphomas].
    Ingen-Housz-Oro S; Bagot M
    Rev Prat; 2009 Nov; 59(9):1207-15. PubMed ID: 19961071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
    Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
    Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous B-cell lymphoma: classification and treatment.
    Willemze R
    Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic principles and new developments in primary cutaneous B-cell lymphomas.
    Kerl H; Kodama K; Cerroni L
    J Dermatol Sci; 2004 May; 34(3):167-75. PubMed ID: 15113586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Homogeneous clinical behavior of a group of cutaneous B-cell lymphomas].
    de Misa RF; Sastre JL; Azaña JM; Escribano L; Suárez J; Bellas C
    Sangre (Barc); 1995 Dec; 40(6):465-70. PubMed ID: 8850229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analytical study of 13 cases of cutaneous lymphoma].
    Kort R; Mokni M; Rouatbi M; Azaiz MI; Kchir N; Haouet S; Boubaker S; Zitouna M; Ben Osman A
    Tunis Med; 1995; 73(6-7):247-52. PubMed ID: 9506173
    [No Abstract]   [Full Text] [Related]  

  • 29. Diffuse large B-cell lymphoma mimicking advanced basal cell carcinoma.
    Akinyemi E; Mai L; Matin A; Maini A
    J Natl Med Assoc; 2007 Aug; 99(8):948-50. PubMed ID: 17722675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of cutaneous B-cell lymphoma showing multiple lipoatrophy-like skin depressions.
    Itoh S; Okada N; Wakasa T; Tsudo M; Shintaku M; Kimura T; Horiguchi Y
    Int J Dermatol; 2010 Mar; 49(3):339-41. PubMed ID: 20465679
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management.
    Sokol L; Naghashpour M; Glass LF
    Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New and experimental skin-directed therapies for cutaneous lymphomas.
    Farkas A; Kemeny L; French LE; Dummer R
    Skin Pharmacol Physiol; 2009; 22(6):322-34. PubMed ID: 19786826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous B-cell lymphoma].
    Cortés B; Prins C
    Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
    Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
    Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intralesional agents in the management of cutaneous malignancy: a review.
    Good LM; Miller MD; High WA
    J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.
    Fernández-Guarino M; Ortiz-Romero PL; Fernández-Misa R; Montalbán C
    Actas Dermosifiliogr; 2014 Jun; 105(5):438-45. PubMed ID: 23540593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standard and new treatments in cutaneous B-cell lymphomas.
    Dreno B
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():47-51. PubMed ID: 16412212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
    Vural F; Saydam G; Cagirgan S; Ertekin B; Hekimgil M; Unal I; Soydan S; Tombuloglu M
    Int J Dermatol; 2008 Jul; 47(7):675-80. PubMed ID: 18613872
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.